Related Experiment Video
Updated: Jul 20, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Quality of life and health status in interstitial lung diseases
Jolanda De Vries1, Marjolein Drent
1Department of Psychology and Health, Medical Psychology, Tilburg University and St Elisabeth Hospital, The Netherlands. j.devries@uvt.nl
Purpose Of Review:
The aim of this review is to provide information on the influence of interstitial lung disease on patients' health status and quality of life, with an emphasis on which aspects might be affected by interstitial lung disease.
Recent Findings:
The quality of life of sarcoidosis patients with current symptoms and patients with idiopathic pulmonary fibrosis is mainly impaired in the domains of physical health and level of independence. Concerning health status, sarcoidosis patients report reduced physical functioning, especially when they have current symptoms. The health status of idiopathic pulmonary fibrosis patients is impaired in almost all aspects. Subjectively assessed dyspnea is related to health status. A relationship between treatment and health status has not been found.
Summary:
Results from the existing studies show that both illnesses have a substantial impact on patients' life. Studies aiming at measuring quality of life or health status in other interstitial lung diseases are scarce or nonexistent.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations